page_banner

products

Chemical API CAS 84485-00-7 HCL Sibutramine

short description:


  • Common name: Sibutramine
  • CAS No.: 84485-00-7
  • MF: C17H26ClN
  • MW: 279.848
  • Melting point: 190-200ºC
  • Boiling point : 342.6±25.0 °C at 760 mmHg
  • density : 1.0±0.1 g/cm3
  • Flash Point: 161.0±23.2 °C
  • Exact Mass: 279.175385
  • PSA: 3.24000
  • Package: Bag,Carton
  • Express: DHL,UPS,FedEx,Postal and so on.
  • Payment method: Bank transfer,Bitcoin,Western Union and so on
  • whatsapp: 008618034511316
  • wickr/ telegram: daisey521
  • Product Detail

    Product Tags

    Wickr/Telegram  :   Daisey521

    Whatsapp  :   008618034511316

    Skype:          live:.cid.93f1bd48473d87a8

    Email:        saleroom@yeah.net

    Basic Information

    Sibutramine hydrochloride is a weight-loss drug, which is the hydrochloride form of sibutramine. Its pharmacological action is completely the same as sibutramine, but its stability and solubility are better than sibutramine.
    Sibutramine hydrochloride was first used to treat depression. In its clinical application, people found that its weight reduction effect was significantly stronger than its antidepressant effect.
    On the one hand, it can reduce hunger and effectively control caloric intake by inhibiting serotonin reuptake;
    On the other hand, it can increase the consumption of adipose tissue, enhance metabolism and promote energy consumption by activating adrenergic receptors;
    It has obvious weight loss effect, but it may cause serious side effects such as increased blood pressure, increased heart rate, anorexia, insomnia, abnormal liver function, etc.
    Use: as antidepressant

    CAS 94-15-5
    Levamisole
    Levamisole

    Usage

    Sibutramine hydrochloride, a 5-hydroxytryptamine and norepinephrine reuptake inhibitor, has dual effects of inhibiting appetite and enhancing metabolism, and is used for the treatment of obesity that cannot be controlled by diet and exercise.
    Sibutramine hydrochloride has many clinical contraindications, such as severe hypertension, severe liver and renal insufficiency
    1. The treatment of obesity should be based on diet control and exercise.
    2. Obesity caused by Cushing's syndrome and hypothyroidism should be excluded from the scope of application of this product.
    3. Patients with a history of hypertension should use it cautiously.
    4. Patients with gallstones should use this product with caution because it may increase or aggravate the formation of gallstones.
    5. This product can cause pupil dilation, and should be carefully used in patients with angle-closure glaucoma.
    6. Patients with a history of epilepsy should use it with caution, and patients with epilepsy should stop using it.
    7. It may affect judgment, thinking or motor skills.


  • Previous:
  • Next:

  • Write your message here and send it to us